Riluzole contains not less than 98.0 percent and not more than 102.0 percent of C8H5F3N2OS calculated on the anhydrous basis.

"台灣神隆"瑞隆首
Riluzole "SPT"

• 申請商: 台灣神隆股份有限公司
• 適應症: 肌萎縮脊髓側索硬化症。
• 含量: 0